000 01115 a2200313 4500
005 20250517204633.0
008 ####s 0 0 eng d
022 _a1949-2553
024 7 _a10.18632/oncotarget.24298
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aJilkova, Zuzana Macek
245 0 0 _aCombination of AKT inhibitor ARQ 092 and sorafenib potentiates inhibition of tumor progression in cirrhotic rat model of hepatocellular carcinoma.
_h[electronic resource]
260 _bOncotarget
_cFeb 2018
300 _a11145-11158 p.
_bdigital
500 _aPublication Type: Journal Article
700 1 _aKuyucu, Ayca Zeybek
700 1 _aKurma, Keerthi
700 1 _aAhmad Pour, Séyédéh Tayébéh
700 1 _aRoth, Gaël S
700 1 _aAbbadessa, Giovanni
700 1 _aYu, Yi
700 1 _aSchwartz, Brian
700 1 _aSturm, Nathalie
700 1 _aMarche, Patrice N
700 1 _aHainaut, Pierre
700 1 _aDecaens, Thomas
773 0 _tOncotarget
_gvol. 9
_gno. 13
_gp. 11145-11158
856 4 0 _uhttps://doi.org/10.18632/oncotarget.24298
_zAvailable from publisher's website
999 _c28181137
_d28181137